Paradigm Asset Management Co. LLC Sells 500 Shares of Roche Holding AG (OTCMKTS:RHHBY)

Paradigm Asset Management Co. LLC cut its position in Roche Holding AG (OTCMKTS:RHHBY) by 9.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,651 shares of the company’s stock after selling 500 shares during the quarter. Paradigm Asset Management Co. LLC’s holdings in Roche were worth $186,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in the company. SVB Wealth LLC grew its position in Roche by 2.6% during the first quarter. SVB Wealth LLC now owns 16,646 shares of the company’s stock worth $531,000 after buying an additional 426 shares in the last quarter. Confluence Investment Management LLC grew its position in Roche by 3.7% during the second quarter. Confluence Investment Management LLC now owns 12,922 shares of the company’s stock worth $448,000 after buying an additional 459 shares in the last quarter. Norman Fields Gottscho Capital Management LLC boosted its holdings in shares of Roche by 2.3% in the 2nd quarter. Norman Fields Gottscho Capital Management LLC now owns 24,650 shares of the company’s stock worth $858,000 after purchasing an additional 550 shares in the last quarter. Archer Investment Corp boosted its holdings in shares of Roche by 10.6% in the 2nd quarter. Archer Investment Corp now owns 6,810 shares of the company’s stock worth $236,000 after purchasing an additional 652 shares in the last quarter. Finally, Hancock Whitney Corp boosted its holdings in shares of Roche by 2.4% in the 1st quarter. Hancock Whitney Corp now owns 28,995 shares of the company’s stock worth $926,000 after purchasing an additional 678 shares in the last quarter.

Wall Street Analyst Weigh In

RHHBY has been the subject of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft lowered Roche from a “hold” rating to a “sell” rating in a research report on Friday, September 13th. Bank of America raised Roche from a “neutral” rating to a “buy” rating in a research report on Friday, September 13th. Three equities research analysts have rated the stock with a sell rating, one has issued a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold”.

Roche Trading Down 0.7 %

Shares of RHHBY opened at $37.35 on Wednesday. The business’s fifty day simple moving average is $39.21 and its two-hundred day simple moving average is $37.04. Roche Holding AG has a 12 month low of $29.20 and a 12 month high of $42.43.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.